vs
MANITOWOC CO INC（MTW）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
MANITOWOC CO INC的季度营收约是Royalty Pharma plc的1.1倍（$677.1M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 1.0%，领先33.4%），MANITOWOC CO INC同比增速更快（13.6% vs 4.8%），过去两年MANITOWOC CO INC的营收复合增速更高（16.9% vs 4.6%）
马尼托瓦克公司是一家美国工程机械制造企业，创立于1902年，核心产品为起重机械，历史上曾生产商用制冷设备与船舶设备。公司通过全资子公司，围绕Grove、马尼托瓦克、Potain等多个品牌，设计、生产、销售移动式伸缩臂起重机、塔式起重机、履带式起重机等设备，并提供相关售后服务支持。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
MTW vs RPRX — 直观对比
营收规模更大
MTW
是对方的1.1倍
$622.0M
营收增速更快
MTW
高出8.8%
4.8%
净利率更高
RPRX
高出33.4%
1.0%
两年增速更快
MTW
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $677.1M | $622.0M |
| 净利润 | $7.0M | $214.2M |
| 毛利率 | 16.7% | — |
| 营业利润率 | 3.0% | 62.4% |
| 净利率 | 1.0% | 34.4% |
| 营收同比 | 13.6% | 4.8% |
| 净利润同比 | -87.7% | 2.9% |
| 每股收益（稀释后） | $0.20 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MTWRPRX
| Q4 25 | $677.1M | $622.0M | ||
| Q3 25 | $553.4M | $609.3M | ||
| Q2 25 | $539.5M | $578.7M | ||
| Q1 25 | $470.9M | $568.2M | ||
| Q4 24 | $596.0M | $593.6M | ||
| Q3 24 | $524.8M | $564.7M | ||
| Q2 24 | $562.1M | $537.3M | ||
| Q1 24 | $495.1M | $568.0M |
净利润MTWRPRX
| Q4 25 | $7.0M | $214.2M | ||
| Q3 25 | $5.0M | $288.2M | ||
| Q2 25 | $1.5M | $30.2M | ||
| Q1 25 | $-6.3M | $238.3M | ||
| Q4 24 | $56.7M | $208.2M | ||
| Q3 24 | $-7.0M | $544.0M | ||
| Q2 24 | $1.6M | $102.0M | ||
| Q1 24 | $4.5M | $4.8M |
毛利率MTWRPRX
| Q4 25 | 16.7% | — | ||
| Q3 25 | 18.5% | — | ||
| Q2 25 | 18.4% | — | ||
| Q1 25 | 19.1% | — | ||
| Q4 24 | 16.0% | — | ||
| Q3 24 | 16.7% | — | ||
| Q2 24 | 17.7% | — | ||
| Q1 24 | 18.7% | — |
营业利润率MTWRPRX
| Q4 25 | 3.0% | 62.4% | ||
| Q3 25 | 3.3% | 70.1% | ||
| Q2 25 | 1.8% | 36.3% | ||
| Q1 25 | 1.1% | 94.0% | ||
| Q4 24 | 2.7% | 60.9% | ||
| Q3 24 | 1.4% | — | ||
| Q2 24 | 2.3% | 50.2% | ||
| Q1 24 | 3.1% | -13.0% |
净利率MTWRPRX
| Q4 25 | 1.0% | 34.4% | ||
| Q3 25 | 0.9% | 47.3% | ||
| Q2 25 | 0.3% | 5.2% | ||
| Q1 25 | -1.3% | 41.9% | ||
| Q4 24 | 9.5% | 35.1% | ||
| Q3 24 | -1.3% | 96.3% | ||
| Q2 24 | 0.3% | 19.0% | ||
| Q1 24 | 0.9% | 0.8% |
每股收益（稀释后）MTWRPRX
| Q4 25 | $0.20 | $0.49 | ||
| Q3 25 | $0.14 | $0.67 | ||
| Q2 25 | $0.04 | $0.07 | ||
| Q1 25 | $-0.18 | $0.55 | ||
| Q4 24 | $1.60 | $0.46 | ||
| Q3 24 | $-0.20 | $1.21 | ||
| Q2 24 | $0.04 | $0.23 | ||
| Q1 24 | $0.12 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $77.3M | $618.7M |
| 总债务越低越好 | $447.1M | $9.0B |
| 股东权益账面价值 | $695.2M | $9.7B |
| 总资产 | $1.8B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.64× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资MTWRPRX
| Q4 25 | $77.3M | $618.7M | ||
| Q3 25 | $39.7M | $938.9M | ||
| Q2 25 | $32.9M | $631.9M | ||
| Q1 25 | $41.4M | $1.1B | ||
| Q4 24 | $48.0M | $929.0M | ||
| Q3 24 | $22.9M | $950.1M | ||
| Q2 24 | $38.1M | $1.8B | ||
| Q1 24 | $31.5M | $843.0M |
总债务MTWRPRX
| Q4 25 | $447.1M | $9.0B | ||
| Q3 25 | $479.9M | $8.9B | ||
| Q2 25 | $459.8M | $8.0B | ||
| Q1 25 | $381.4M | $7.6B | ||
| Q4 24 | $377.1M | $7.6B | ||
| Q3 24 | $426.7M | $7.6B | ||
| Q2 24 | $406.3M | $7.6B | ||
| Q1 24 | $372.7M | $6.1B |
股东权益MTWRPRX
| Q4 25 | $695.2M | $9.7B | ||
| Q3 25 | $682.7M | $9.6B | ||
| Q2 25 | $681.3M | $9.5B | ||
| Q1 25 | $651.6M | $9.8B | ||
| Q4 24 | $640.1M | $10.3B | ||
| Q3 24 | $607.6M | $10.3B | ||
| Q2 24 | $592.3M | $9.8B | ||
| Q1 24 | $596.0M | $9.9B |
总资产MTWRPRX
| Q4 25 | $1.8B | $19.6B | ||
| Q3 25 | $1.9B | $19.3B | ||
| Q2 25 | $1.9B | $18.3B | ||
| Q1 25 | $1.8B | $17.6B | ||
| Q4 24 | $1.7B | $18.2B | ||
| Q3 24 | $1.8B | $18.0B | ||
| Q2 24 | $1.7B | $17.7B | ||
| Q1 24 | $1.8B | $16.1B |
负债/权益比MTWRPRX
| Q4 25 | 0.64× | 0.92× | ||
| Q3 25 | 0.70× | 0.93× | ||
| Q2 25 | 0.67× | 0.84× | ||
| Q1 25 | 0.59× | 0.78× | ||
| Q4 24 | 0.59× | 0.74× | ||
| Q3 24 | 0.70× | 0.74× | ||
| Q2 24 | 0.69× | 0.78× | ||
| Q1 24 | 0.63× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $91.1M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $78.3M | — |
| 自由现金流率自由现金流/营收 | 11.6% | — |
| 资本支出强度资本支出/营收 | 1.9% | — |
| 现金转化率经营现金流/净利润 | 13.01× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $-15.3M | — |
8季度趋势，按日历期对齐
经营现金流MTWRPRX
| Q4 25 | $91.1M | $827.1M | ||
| Q3 25 | $-14.1M | $702.6M | ||
| Q2 25 | $-67.7M | $364.0M | ||
| Q1 25 | $12.9M | $596.1M | ||
| Q4 24 | $112.4M | $742.5M | ||
| Q3 24 | $-43.6M | $703.6M | ||
| Q2 24 | $11.0M | $658.2M | ||
| Q1 24 | $-30.6M | $664.6M |
自由现金流MTWRPRX
| Q4 25 | $78.3M | — | ||
| Q3 25 | $-22.0M | — | ||
| Q2 25 | $-73.7M | — | ||
| Q1 25 | $2.1M | — | ||
| Q4 24 | $101.1M | — | ||
| Q3 24 | $-52.9M | — | ||
| Q2 24 | $-1.9M | — | ||
| Q1 24 | $-42.8M | — |
自由现金流率MTWRPRX
| Q4 25 | 11.6% | — | ||
| Q3 25 | -4.0% | — | ||
| Q2 25 | -13.7% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 17.0% | — | ||
| Q3 24 | -10.1% | — | ||
| Q2 24 | -0.3% | — | ||
| Q1 24 | -8.6% | — |
资本支出强度MTWRPRX
| Q4 25 | 1.9% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 2.3% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 1.8% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | 2.5% | — |
现金转化率MTWRPRX
| Q4 25 | 13.01× | 3.86× | ||
| Q3 25 | -2.82× | 2.44× | ||
| Q2 25 | -45.13× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | 1.98× | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | 6.88× | 6.45× | ||
| Q1 24 | -6.80× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MTW
| US | $344.5M | 51% |
| Europe | $193.8M | 29% |
| Other Countries | $138.8M | 20% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
